Smith & Nephew (SNN) Shares Outstanding (2009 - 2025)

Smith & Nephew (SNN) posted quarterly Shares Outstanding (Entity) of $867.0 million for Q4 2025, down 0.69% year-on-year from $873.0 million in Q4 2024, and down 0.69% on a QoQ basis from $873.0 million in Q4 2024.

Smith & Nephew (SNN) Shares Outstanding (2009 - 2025) Analysis & Trends

Smith & Nephew (SNN) has reported Shares Outstanding (Entity) for 17 consecutive years, with $867.0 million the latest figure, recorded in Q4 2025.

  • Quarterly Shares Outstanding (Entity) fell 0.69% year-over-year to $867.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $867.0 million (down 0.69% YoY) and the FY2025 annual result came in at $867.0 million, down 0.69% from the prior year.
  • Shares Outstanding (Entity) declined to $867.0 million in Q4 2025 per SNN's latest filing, from $873.0 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Entity) for SNN reached as high as $877.0 million in Q4 2021 and fell as low as $867.0 million in Q4 2025.
  • A 5-year average of $872.0 million and a median of $872.0 million in 2022 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) increased 0.23% — and 2025, when it retreated 0.69%.
  • Year by year, Shares Outstanding (Entity) stood at $877.0 million in 2021, then slipped by 0.57% to $872.0 million in 2022, then declined by 0.11% to $871.0 million in 2023, then rose by 0.23% to $873.0 million in 2024, then retreated by 0.69% to $867.0 million in 2025.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $867.0 million, $873.0 million, and $871.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 1.74 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 382.90 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.28 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 579.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 385.10 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 951.57 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 456.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 867.00 Mn
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 98.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 867.00 Mn
Jun 28, 2025 873.00 Mn
Dec 31, 2024 873.00 Mn
Jun 29, 2024 871.00 Mn
Dec 31, 2023 871.00 Mn
Dec 31, 2022 872.00 Mn
Dec 31, 2021 877.00 Mn
Dec 31, 2020 875.00 Mn
Jun 30, 2020 874.00 Mn
Dec 31, 2019 874.00 Mn
Jun 29, 2019 873.00 Mn
Dec 31, 2018 873.00 Mn
Jun 30, 2018 874.00 Mn
Dec 31, 2017 874.00 Mn
Dec 31, 2016 890.00 Mn
Dec 31, 2015 894.00 Mn
Jun 30, 2015 894.00 Mn
Dec 31, 2014 901.00 Mn
Sep 30, 2014 2.26 Bn
Jun 28, 2014 2.23 Bn